华熙生物“出局”科创50指数 去年已无10亿元级护肤品牌

Group 1 - The Shanghai Stock Exchange and China Securities Index Co., Ltd. announced the periodic adjustment results for indices such as SSE 50, SSE 180, SSE 380, and Sci-Tech 50, effective after market close on December 12, 2025, with changes including 4 samples for SSE 50, 7 for SSE 180, 38 for SSE 380, and 2 for Sci-Tech 50 [1] - Huaxi Biological was removed from the Sci-Tech 50 index adjustment list [2] - The adjustment of Huaxi Biological has been anticipated, as the company reported a significant decline in its skin science innovation transformation business, with no brands achieving over 1 billion in revenue last year [3][4] Group 2 - In the 2024 annual report, Huaxi Biological renamed its "Personal Health Consumer Products Business Line" to "Skin Science Innovation Transformation Business Line," which generated revenue of 2.569 billion yuan, a year-on-year decrease of 31.62%, accounting for 47.92% of the company's main business revenue [4] - The revenue breakdown for Huaxi Biological's brands includes 923 million yuan for Runbaiyan, 649 million yuan for Kuaidi, 290 million yuan for Mibeier, and 279 million yuan for BM Jihuo, indicating the absence of any 1 billion-level skincare brands [4]